Royal Philips : Frost & Sullivan recognizes power of connected medication adherence technology to drive value-based care

'To achieve the highest medication compliancy rate, it is important to have an integrated ecosystem that enables 100 percent transparency between the patient and various stakeholders along the care journey,' said Divyaa Ravishankar, Industry Principal & Associate Fellow, Transformational Health, Frost & Sullivan. 'PMAS is the only solution that offers an integrated and connected environment, and Frost & Sullivan analysis supports the fact that, if used diligently, PMAS can have a disruptive impact on the overall healthcare expenditure.'

To help facilitate the delivery of proactive and preventative care, Philips' connected ecosystem includes a monitored in-home dispensing device, pre-packaged, unit-dose medications from mail order and specialty pharmacies, a clinician portal and a caregiver app. The advanced solution provides clinicians, pharmacists and caregivers with daily notifications of non-adherent patients, ensuring potential health risks are addressed before they escalate, while helping to drive down costs of medical complications related to non-adherence, such as unnecessary hospital admissions. PMAS provides the stability and transparency needed to help patients successfully manage their mediations, particularly for those with chronic conditions.